ICICI Bank Limited (IBN) Stock Price & Analysis
ICICI Bank Limited (IBN) is trading at USD 29.38, down 1.87% today, as of October 23, 2026 at 17:27 UTC (US market open; quotes may be delayed), according to Nexqual market data.
IBN last closed at USD 29.94; today's session has ranged USD 29.34–29.7 on volume of 2,160,011 shares. Market capitalization is $105.47B, with a 52-week range of USD 25.08–31.78 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 17:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IBN.md
Key facts (IBN)
- 2 of 80 tracked superinvestors hold IBN (13F, Q2 2026): 0 new, 0 added, 2 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 3 Form 4 filings, $3.0M; 3 not under a Rule 10b5-1 plan ($3.0M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.75 on a 1–5 scale) (4 analysts), mean target USD 37.75 (range 36–40).
- Total return with dividends: 1Y -4.9% vs S&P 500 +14.4%; 5Y +44.4% vs S&P 500 +77.0%.
- Next earnings: 2027-01-14, EPS estimate USD 0.45, revenue estimate $323B.
Superinvestors (SEC 13F-HR, Q2 2026) (IBN)
2 of 80 tracked investors hold IBN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Sarah Ketterer | Causeway Capital Management | 0.14% | $13.0M | Reduced -0.7% |
| Polen Capital | Polen Capital Management | 0.01% | $1.1M | Reduced -67.7% |
Insider sales (SEC Form 4, open-market, last ~7 months) (IBN)
0 of 3 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-04-24 | Jha Rakesh | Director | 45,000 | $634K | 27.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-21…2026-04-23 | Jha Rakesh | Director | 135,000 | $2.0M | 58.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-21 | Bakhshi Sandeep | Chief Executive Officer | 24,999 | $374K | 2.3% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (IBN)
Consensus Buy (mean 1.75 on a 1–5 scale), 4 analysts; mean target USD 37.75 (low 36, high 40).
Total return (dividends reinvested) (IBN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -4.9% | +44.4% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -4.9% | +7.6% |
| Volatility (annualized) | 21.5% | 22.6% |
| Max drawdown | -19.7% (Jan 2026→Mar 2026) | -25.9% (May 2025→Mar 2026) |
IBN suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | India | “and letters of credit, are similar to the products offered to our customers in India.” |
| Partner | PRUDENTIAL PLC (PUK) | “partner, Prudential Corporation Holdings Limited (“PCHL”), made an announcement regarding a potential listing of and” |
Quoted from the company's 20-F filed Jul 20, 2026.
Companies that name IBN in their SEC reports
| Relationship to IBN | Company | Filing | Sentence |
|---|---|---|---|
| partner | PRUDENTIAL PLC (PUK) | 20-F Mar 26, 2026 | “International Holdings Limited (BOCI) and until December 2025 an asset management joint venture in India with ICICI Bank (see” |
IBN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.45 | $0.38 | +16.5% | $323.47B | 1 |
| Next quarter (ends Mar 2027) | $0.45 | $0.41 | +11.9% | $337.95B | 1 |
| Current fiscal year (ends Mar 2027) | $1.73 | $1.60 | +8.3% | $1.38T | 2 |
| Next fiscal year (ends Mar 2028) | $2.01 | $1.85 | +8.8% | $1.63T | 2 |
Key Statistics (as of October 23, 2026 at 17:28 UTC)
| Price | USD 29.38 |
|---|---|
| Change | ▼ 1.87% (down) |
| Previous Close | USD 29.94 |
| Open | USD 29.53 |
| Day Range | USD 29.34 – 29.7 |
| 52-Week Range | USD 25.08 – 31.78 |
| Volume | 2,160,011 shares |
| Market Cap | $105.47B |
| Exchange | NYQ |
Technical Analysis (IBN)
Nexqual's technical model rates IBN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of October 23, 2026 at 17:28 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.39 (neutral) |
| vs SMA50 | Above (USD 28.95) |
| MACD | 0.31 (positive) |
Analyst Ratings (IBN)
Wall Street analysts rate IBN "Buy" based on 4 analysts, with a mean price target of USD 37.75 (range USD 36–40), per Nexqual as of October 23, 2026 at 17:28 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 37.75 |
| High Target | USD 40 |
| Low Target | USD 36 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (IBN)
| Next Earnings Date | 2027-01-14 |
|---|---|
| EPS Estimate | USD 0.45 |
| Revenue Estimate | $323.47B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.43 vs est 0.38 ▲ beat |
| 2026-06-30 | USD 0.42 vs est 0.41 ▲ beat |
| 2026-03-31 | USD 0.41 vs est 0.39 ▲ beat |
| 2025-12-31 | USD 0.34 vs est 0.38 ▼ miss |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financials & Fundamentals (IBN)
| Total Revenue | $2.12T |
|---|---|
| Revenue Growth (latest quarter, YoY) | +15.80% |
| Gross Margin | +0.00% |
| Operating Margin | +37.52% |
| Profit Margin | +27.84% |
| ROE | +16.49% |
| Total Cash | $2.75T |
| Total Debt | $2.96T |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financial Health Score (IBN)
Nexqual rates ICICI Bank Limited's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 17:28 UTC.
| Growth | Critical — Revenue -42% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Net margin 42% (last 12 months); banks have no gross margin |
| Balance Sheet | N/A — Not comparable for banks: deposits and customer funds sit on the balance sheet, so cash vs debt does not measure safety (SEC industry: Commercial Banks, NEC) |
| Cash Flow | N/A — Not meaningful for banks and lenders: lending and trading move operating cash flow by billions each year (SEC industry: Commercial Banks, NEC) |
| Efficiency | Solid — ROE 16%, ROA 2.1% |
Ownership (IBN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +16.39% |
| Shares Outstanding | 3.59B |
| Float | 3.57B |
| Short % of Float | +1.08% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Leadership (IBN)
ICICI Bank Limited is led by Sandeep Bakhshi B.E., MD, CEO & Executive Director, per Nexqual as of October 23, 2026 at 17:28 UTC.
| MD, CEO & Executive Director | Sandeep Bakhshi B.E. |
|---|---|
| Executive Director | Rakesh Jha BE, PGDM |
| Executive Director | Sandeep Batra A.C.S., B.Com., CA, CS, F.C.A. |
| Executive Director | Ajay Kumar Gupta B.Com, CA |
| Group CFO & Head of Investor Relations | Anindya Banerjee |
Major Backers & Investors (IBN)
Notable institutional backers of ICICI Bank Limited include Morgan Stanley, WCM Investment Management, LLC, GQG Partners LLC, according to Nexqual as of October 23, 2026 at 17:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 1.52% |
| WCM Investment Management, LLC | 1.43% |
| GQG Partners LLC | 0.86% |
| Temasek Holdings (Private) Ltd | 0.81% |
| Robeco Institutional Asset Management B.V. | 0.71% |
| Invesco | 0.68% |
| JPMorgan | 0.64% |
| Schroder Investment Management Group | 0.44% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ITUB | Itau Unibanco Banco Holding SA | USD 9.47 | ▼ 0.21% |
| HDB | HDFC Bank Limited | USD 21.95 | ▼ 2.21% |
| MFG | Mizuho Financial Group, Inc. Sp | USD 9.52 | ▼ 2.01% |
| USB | U.S. Bancorp | USD 59.44 | ▼ 0.97% |
| PNC | PNC Financial Services Group, I | USD 223.68 | ▼ 0.82% |
| LYG | Lloyds Banking Group Plc | USD 5.31 | ▼ 1.39% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt